A Miswired Ovarian Ecosystem: LIF/JAK/STAT3 Distortion in PCOS

Area of Science:

• Reproductive Endocrinology
• Molecular Biology
• Metabolic Disorders

Background:

• Polycystic ovary syndrome (PCOS) is a complex endocrine disorder affecting reproductive and metabolic health.
• The Leukemia Inhibitory Factor (LIF)/Janus Kinase (JAK)/Signal Transducer and Activator of Transcription 3 (STAT3) pathway is crucial for reproductive processes and metabolic balance.

Purpose of the Study:

• To elucidate the role of the LIF/JAK/STAT3 pathway in PCOS pathophysiology.
• To identify how signaling alterations in PCOS contribute to hyperandrogenism, anovulation, and insulin resistance.
• To explore the potential of targeting the LIF/JAK/STAT3 axis for PCOS therapies.

Main Methods:

• Analysis of signaling pathway dysregulation in PCOS.
• Investigation of molecular mechanisms including gene expression, epigenetic modifications, and non-coding RNA involvement.
• Examination of mitochondrial function and crosstalk with other signaling pathways (MAPK/ERK, PI3K/AKT, TLR4/NF-κB, Wnt/β-catenin, Hippo/Notch/YAP).

Main Results:

• PCOS disrupts the LIF/JAK/STAT3 pathway, redirecting STAT3 activation to inflammatory pathways (JAK2/IL-6/leptin).
• This rewiring promotes steroidogenesis, impairs folliculogenesis and endometrial receptivity, and exacerbates insulin resistance.
• Epigenetic changes and non-coding RNAs amplify pathological signaling, while mitochondrial dysfunction worsens metabolic complications.

Conclusions:

• The aberrant LIF/JAK/STAT3 signaling axis is a central player in PCOS pathogenesis.
• Targeting this pathway presents a significant opportunity for developing precise, phenotype-specific therapies for PCOS.
• Interventions like JAK inhibitors and metabolic modulators show promise for PCOS treatment.